Cabot Co. (NYSE:CBT) Receives Average Recommendation of “Hold” from Analysts

Cabot Co. (NYSE:CBTGet Free Report) has been assigned a consensus rating of “Hold” from the five research firms that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $87.67.

A number of research analysts have recently issued reports on the stock. StockNews.com downgraded shares of Cabot from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 14th. UBS Group downgraded shares of Cabot from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $90.00 to $87.00 in a research report on Monday, January 8th. Mizuho assumed coverage on shares of Cabot in a research report on Wednesday, March 27th. They issued a “buy” rating and a $104.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research report on Thursday.

Get Our Latest Stock Report on CBT

Insider Activity at Cabot

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of the company’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the transaction, the executive vice president now owns 97,201 shares in the company, valued at $7,767,331.91. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 3.07% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Chesley Taft & Associates LLC acquired a new position in Cabot during the first quarter worth $203,000. Wealth Enhancement Advisory Services LLC grew its stake in shares of Cabot by 12.5% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 5,924 shares of the specialty chemicals company’s stock worth $546,000 after acquiring an additional 656 shares in the last quarter. Miller Howard Investments Inc. NY bought a new stake in shares of Cabot in the 1st quarter worth $279,000. Banque Cantonale Vaudoise grew its stake in shares of Cabot by 17.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 833 shares of the specialty chemicals company’s stock worth $77,000 after acquiring an additional 124 shares in the last quarter. Finally, Los Angeles Capital Management LLC grew its stake in shares of Cabot by 1.4% in the 1st quarter. Los Angeles Capital Management LLC now owns 10,851 shares of the specialty chemicals company’s stock worth $1,000,000 after acquiring an additional 145 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Stock Performance

Cabot stock traded up $0.18 during midday trading on Thursday, hitting $92.11. The company’s stock had a trading volume of 36,571 shares, compared to its average volume of 305,305. The company has a market cap of $5.11 billion, a price-to-earnings ratio of 11.91, a PEG ratio of 0.98 and a beta of 1.28. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.04 and a quick ratio of 1.30. The company has a 50-day moving average price of $87.85 and a two-hundred day moving average price of $79.41. Cabot has a 1-year low of $63.73 and a 1-year high of $98.34.

Cabot (NYSE:CBTGet Free Report) last posted its earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Cabot had a net margin of 11.24% and a return on equity of 25.52%. The firm had revenue of $958.00 million for the quarter, compared to analyst estimates of $927.28 million. As a group, sell-side analysts predict that Cabot will post 6.58 earnings per share for the current year.

Cabot Company Profile

(Get Free Report

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.